Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

[ABBV](/topic/abbv)

### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:abbv/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/abbv/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Month**: XX% -X%  
**6 Months**: XX% +25%  
**1 Year**: XX% +15%  
**1-Year High**: XXX% on 2025-06-07  
**1-Year Low**: XX% on 2024-10-17  

**Most Supportive Themes**
- **Financial Stability and Positive Sentiment:** (60%) AbbVie's consistent performance, strong pipeline, and XXX% dividend yield, along with positive sentiment from social media users.
- **Exclusive Global Licensing Agreement:** (30%) Global Licensing Agreement for ISB 2001, a first-in-class CD38BCMACD3 Trispecific Antibody, is a news item that drives discussion.
  
**Most Critical Themes**
- **Drug Challenges and Analyst Mentions:** (10%)  Challenges faced by AbbVie (ABBV) with Skyrizi and Rinvoq drugs, and mentions of the stock in posts by accounts that have made large gains following a specific analyst's recommendations.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXXXXXX  | XX% | XXXXXX  | XX% | XXX      | X% |
| TikTok  | XX       | X%  | XXX     | X%  | X        | X% |
| YouTube | XX       | X%  | XX      | X%  | X        | X% |
| Reddit  | XX       | X%  | XX      | X%  | X        | X% |
| News    | X        | X%  | X       | X%  | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXXXX  | XX% | XXXXXX  | XX% | XXX      | X% |

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

ABBV

Sentiment: XX%

Sentiment Line Chart
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Month: XX% -X%
6 Months: XX% +25%
1 Year: XX% +15%
1-Year High: XXX% on 2025-06-07
1-Year Low: XX% on 2024-10-17

Most Supportive Themes

  • Financial Stability and Positive Sentiment: (60%) AbbVie's consistent performance, strong pipeline, and XXX% dividend yield, along with positive sentiment from social media users.
  • Exclusive Global Licensing Agreement: (30%) Global Licensing Agreement for ISB 2001, a first-in-class CD38BCMACD3 Trispecific Antibody, is a news item that drives discussion.

Most Critical Themes

  • Drug Challenges and Analyst Mentions: (10%) Challenges faced by AbbVie (ABBV) with Skyrizi and Rinvoq drugs, and mentions of the stock in posts by accounts that have made large gains following a specific analyst's recommendations.

Network engagement breakdown:

Network Positive % Neutral % Negative %
X XXXXXXX XX% XXXXXX XX% XXX X%
TikTok XX X% XXX X% X X%
YouTube XX X% XX X% X X%
Reddit XX X% XX X% X X%
News X X% X X% X X%
Total XXXXXXX XX% XXXXXX XX% XXX X%
ABBV Sentiment
/topic/abbv/sentiment